Di Saia P J, Morrow C P
Calif Med. 1973 Feb;118(2):13-7.
Pelvic exenteration offers the only possibility for cure in patients who have pelvic recurrence after receiving optimum amounts of irradiation. With improved radiotherapy techniques, the number of patients with isolated central failure is steadily diminishing, but there remains a significant number of patients with recurrent cancer of the cervix after radiation therapy for whom the procedure offers the only chance for life. Each patient must be assessed individually, with the risks of the procedure weighed against the possible benefits. Technical advances continue to reduce the operative mortality and ameliorate the postoperative morbidity associated with pelvic exenteration.
盆腔脏器清除术为接受了足量放疗后出现盆腔复发的患者提供了唯一的治愈可能。随着放疗技术的改进,孤立性中央衰竭患者的数量在稳步减少,但仍有相当数量的宫颈癌患者在放疗后复发,对此手术是他们唯一的生存机会。必须对每位患者进行单独评估,权衡手术风险与可能的获益。技术进步持续降低盆腔脏器清除术的手术死亡率并减轻术后发病率。